Company Filing History:
Years Active: 2004-2005
Title: The Innovative Contributions of James J Cunningham
Introduction
James J Cunningham is a notable inventor based in Chicago, IL, who has made significant contributions to the field of medicine. He holds a total of 4 patents that focus on innovative therapies for treating neoplasia disorders. His work has the potential to impact the lives of many patients suffering from various forms of cancer.
Latest Patents
Cunningham's latest patents include groundbreaking methods for treating neoplasia. One of his inventions is a combination therapy that utilizes a matrix metalloproteinase inhibitor alongside an antineoplastic agent. This invention provides methods to treat or prevent neoplasia disorders in mammals. Another significant patent details a method of using a matrix metalloproteinase inhibitor in conjunction with one or more antineoplastic agents, specifically topoisomerase inhibitors like irinotecan and topotecan, as a combination therapy for neoplasia treatment.
Career Highlights
Throughout his career, Cunningham has worked with prominent companies in the pharmaceutical industry, including G.D. Searle & Company and Pfizer Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in cancer treatment.
Collaborations
Cunningham has collaborated with esteemed colleagues such as John Patrick McKearn and Gary B Gordon. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of medical research.
Conclusion
James J Cunningham's contributions to the field of medicine through his innovative patents demonstrate his commitment to improving cancer treatment. His work continues to inspire future advancements in the medical community.